Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 20,95€(+64,31%). Der Median liegt bei 20,95€(+64,31%).
Kaufen | 2 |
Halten | 0 |
Verkaufen | 0 |
Scoring-Modelle
Dividenden-Strategie | 5 / 15 |
HGI-Strategie | 13 / 18 |
Levermann-Strategie | -4 / 13 |
News
8-12% Dividend Yields From Undervalued REITs
REITs offer the highest dividend yields in a decade. Some yields as much as 12% and those dividends are rising. I present three of my favorite high-yielding REITs.» Mehr auf seekingalpha.com
Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025
The U.S. cannabis industry continues expanding rapidly, with projections suggesting it could reach $45 billion by 2025. More states are legalizing cannabis for medical and recreational use, boosting demand across the nation. Currently, 24 states allow adult-use cannabis, supporting thousands of dispensaries and grow operations. Additionally, the industry provides over 440,000 full-time jobs, strengthening its economic importance. Meanwhile, recent developments in federal policy signal possible changes ahead. Lawmakers are pushing for cannabis reform, and discussions around federal reclassification have gained momentum. As a result, investor interest is rising steadily, especially in real estate tied to cannabis operations. However, navigating this evolving market requires careful attention and research. Therefore, focusing on cannabis REITs with proven portfolios and strong tenants remains a smart strategy. In particular, companies that operate across multiple states offer added stability and diversification.» Mehr auf marijuanastocks.com
NewLake Capital Partners: Ridiculously Cheap Given Its Potential
Despite recent stock price decline, I remain bullish on NLCP due to its high-quality contracts and potential growth catalysts, including cannabis rescheduling and market expansion. NLCP faced challenges in 2024, including failed cannabis initiatives in key states and rent payment issues with tenants like Calypso and Revolutionary Clinics. NLCP's triple-net lease agreements and 100% occupancy rate highlight its strong negotiating power and favorable lease terms, but keep the tenant concentration risk in mind.» Mehr auf seekingalpha.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Dez. 2024 | |
---|---|---|
Umsatz | 12,03 Mio | 2,10% |
Bruttoeinkommen | 11,97 Mio | 39,96% |
Nettoeinkommen | 5,79 Mio | 8,02% |
EBITDA | 9,62 Mio | 19,35% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 275,49 Mio€ |
Anzahl Aktien | 21,45 Mio |
52 Wochen-Hoch/Tief | 19,13€ - 10,77€ |
Dividendenrendite | 12,46% |
Dividenden TTM | 1,59€ |
Beta | 0,95 |
KGV (PE Ratio) | 11,36 |
KGWV (PEG Ratio) | −2,13 |
KBV (PB Ratio) | 0,75 |
KUV (PS Ratio) | 6,17 |
Unternehmensprofil
NewLake Capital Partners ist ein führender Anbieter von Immobilienkapital für staatlich zugelassene Cannabisbetreiber. Das 2019 gegründete Unternehmen ist ein Triple-Net-Lease-REIT, der Industrie- und Einzelhandelsimmobilien durch Sale-Leaseback-Transaktionen, Käufe von Dritten und Build-to-Suit-Projekte erwirbt. Seine Mieter sind einige der führenden Betreiber in der staatlich lizenzierten Cannabisbranche in den USA und er ist ein zuverlässiger Partner für deren Immobilienbedarf.
Name | Newlake Capital Partners Inc. |
CEO | Anthony Coniglio CPA |
Sitz | New Canaan, ct USA |
Website | |
Industrie | Immobilienmanagement und - entwicklung |
Börsengang | |
Mitarbeiter | 8 |
Ticker Symbole
Börse | Symbol |
---|---|
Pnk | NLCP |
Assets entdecken
Shareholder von Newlake Capital Partners Inc. investieren auch in folgende Assets